Invested in Sustainable Value Creation

Wavelength’s Operating Executives specialize in the
nexus of Lifesciences, Healthcare, and Technology.

We focus on delivering sustainable value...
not on account development.

Expertise Bound With Long Term Perspective

Wavelength’s Operating Executives specialize in the nexus of Lifesciences, Healthcare, and Technology. We deliver transformations resulting in sustainable business value.

We solve complex problems with small teams possessing deep industry expertise. Rolling up our sleeves, we get our hands dirty and work quickly to distill and resolve your needs - driven by an energy and passion for great results. You can count on us to introduce fresh, sound ideas tempered by an experience-tested dose of realism. We always align with our business partners through shared interests.

Our approach will be most refreshing if you’ve ever been oversupplied with high dollar, marginal talent, sold work that didn’t move the needle on the business, or received a strategic plan filled with bright, but flawed and non-implementable ideas.

We’ve held many roles - executives, entrepreneurs, and consultants. These experiences mean we have seen numerous scenarios from multiple viewpoints. You will never have to question our loyalty. When you partner with us, it’s your agenda, period.

If all this resonates with you, then we are

... on your Wavelength

Global News in Lifesciences, Healthcare, and Technology

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

THOUSAND OAKS, Calif., April 16, 2021 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prim...
Biopharmaceuticals, Oncology, Mergers & Acquisitions
Amgen, Five Prime Therapeutics, immunotherapy, targeted therapy

Comcast xFi Advanced Gateway Modem/Router

Here is Comcast?s most advanced modem/router which promises speed as well as ease of use.

Lilly requests revocation of emergency use authorization for bamlanivimab alone to complete transition to bamlanivimab and etesevimab together for treatment of COVID-19 in the U.S.

Final step in Lilly's planned transition to provide only bamlanivimab and etesevimab together in the U.S. Bamlanivimab and etesevimab together now fully available across the U.S. Lilly, in collaboration with Amgen, expects to manufacture sufficient s...
Biopharmaceuticals, FDA
Eli Lilly, bamlanivimab, etesevimab, COVID-19, coronavirus

Harman Kardon ? Home Speaker with Cortana

Here is a premium home speaker with superior sound coupled with Microsoft?s Cortana